GILD: Gilead Sciences, Inc. Stock Live Price Graph
Gilead Sciences, Inc. stock live price (US Dollar), charts and analysis. Get GILD stock market news.
Gilead Sciences, Inc. (GILD)
Loading chart...
About the company
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Company profile
Market News & Analysis
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $0.82 | $0.82 | 2.22% | - |
What Is GILD? Live GILD Prices and Analysis
Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative medicines in areas of unmet medical needs. Founded in 1987, Gilead has become a leader in antiviral therapies, particularly in the treatment of HIV, hepatitis B, hepatitis C, and influenza. The company's emphasis on research and development has made it a key player in the biotechnology sector, attracting significant interest from investors seeking exposure to the healthcare market.
Investors closely follow GILD due to its strong earnings potential, robust pipeline of drugs, and the critical role it plays in treating various viral infections. With a focus on innovative therapies, Gilead has positioned itself as a vital contributor to global health, making it an important stock for those interested in biotechnology investments.
Frequently asked questions
What is the GILD stock price?
The latest GILD (Gilead Sciences, Inc. (GILD)) stock price is 146.8500 USD. Follow the live quote and chart on this page for real-time updates.
What are GILD's intraday ceiling and floor prices?
For GILD, the intraday ceiling is 148.6000 USD and the floor is 144.8500 USD. These levels may update during the session.
What is GILD's previous closing price?
The previous closing price for GILD is 144.2300 USD.
What is GILD's trading volume?
The current trading volume for GILD is 4,960,247. Volume can change throughout the session.
Where can I see the live GILD price?
You can follow the live GILD (Gilead Sciences, Inc. (GILD)) price in the quote area and chart at the top of this Investvio overview page.
Where can I see GILD historical prices and charts?
The current price chart for GILD (Gilead Sciences, Inc. (GILD)) is on this overview page. For longer historical prices and archive data, open the Archive tab and choose a period to review past performance.